Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective, Multicenter, Observational Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole

NCT04735367 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT04735367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04735367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective, Multicenter, Observational Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus Letrozole
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
February 3, 2021
Completion date
September 29, 2023
Enrollment
42 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer